Pipeline

Orphan diseases

Disease
Project
Stage
Cystic fibrosis
Tigeraze ® (dornase alfa)
Pre-clinical
Phase 1
Phase 2
Phase 3
Hereditary angioedema
GNR-038
Pre-clinical
Phase 1
Phase 2
Phase 3
Lysosomal storage disorder
GNR-055
Pre-clinical
Phase 1
Phase 2
Phase 3

Autoimmune diseases

Bronchial asthma
Genolair ® (omalizumab)
Pre-clinical
Phase 1
Phase 2
Phase 3

Oncology

Lymphomas, leukemias
GNR-084 (bispecific antibody, T-cells engager)
Pre-clinical
Phase 1
Phase 2
Phase 3
Solid tumors
GNR-051 (PD-1 inhibitor)
Pre-clinical
Phase 1
Phase 2
Phase 3

Cardiovascular disorders

Myocardial Infarction
GNR-060
Pre-clinical
Phase 1
Phase 2
Phase 3

Ophtalmology

Macular degeneration
GNR-067 (ranibizumab)
Pre-clinical
Phase 1
Phase 2
Phase 3

ATMP

Autologus ATMP
GNR-079 (Cartilage implant)
Pre-clinical
Phase 1
Phase 2
Phase 3
Allogenic ATMP
GNR-080 (Regeneration stimulator)
Pre-clinical
Phase 1
Phase 2
Phase 3